Opko Health Inc. (OPK) — Analysis Summary
Opko Health Inc. (OPK) has a market cap of $928.76M with year-over-year revenue growth of -14.9%. Net margin stands at -37.2%. The stock trades at a P/E ratio of -4.4.
Key Takeaways
- Revenue changed -14.9% year-over-year
- Net margin of -37.2%
- P/E ratio of -4.4
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, OPK posted revenue growth of -14.9% and trades at a P/E of -4.4.
Opko Health Inc. (OPK)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -22.4x — earnings do not cover interest payments
Operating margin at -17.4% — material operating losses
Net margin at -36.6% — significant losses
The latest filing shows negative free cash flow.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Sector
PHARMACEUTICAL PREPARATIONS
Employees
2,275
Headquarters
MIAMI, FL
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.